You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 8,183,042

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,183,042

Title:	Multi-layered implant prepared by a method of tissue repair using a multi-layered matrix
Abstract:	A multi-layered matrix, a method of tissue repair using the same, and multi-layered implant prepared thereof are provided. The multi-layered matrix comprises a first element and a second element connected thereto, and the second element comprises a hollow cavity. The first and the second elements are composed of a composite material comprising a bioabsorbable porous material.
Inventor(s):	Liao; Chun-Jan (Taipei, TW), Jiang; Ching-Chuan (Taipei, TW), Chiang; Hong-Sen (Taipei, TW), Lin; Yu-Ru (Ilan, TW)
Assignee:	Industrial Technology Research Institute (Hsinchu, TW) National Taiwan University Hospital (Taipei, TW)
Application Number:	12/385,781
Patent Claims:	1. A multi-layered implant for directly implanting into a defect site of a living subject, the multi-layered implant comprising: i) a multi-layered matrix comprising a first element and a second element connected thereto, wherein the first and the second elements are composed of a composite material comprising a bioabsorbable porous material and the second element comprises a hollow cavity; and ii) a cell block seeded into the hollow cavity of the second element of the multi-layered matrix, wherein the cell block is enzyme-treated for 4 hours before being seeded into the hollow cavity, and wherein the multi-layered matrix containing the cell block is directly implanted into the defect site of the living subject without an ex vivo incubation. 2. The implant as claimed in claim 1, wherein the bioabsorbable porous material comprises polylactic acid (PLA), polyglycolic acid (PGA), poly (glycolide co-lactide) (PLGA), polyanhydride, polycaprolactone (PCL), polydiester, polyorthoester, collagen, gelatin, hyaluronic acid, chitosan, or polyethylene glycol (PEG), or a mixture thereof. 3. The implant as claimed in claim 1, wherein the composite material further comprises a second material, wherein the second material comprises hydroxyapatite (HAP), tricalcium phosphate (TCP), tetracalcium phosphate (TTCP), dicalcium phosphate anhydrous (DCPA), dicalcium phosphate dihydrate (DCPD), octacalcium phosphate (OCP), or calcium pyrophosphate (CPP), or a mixture thereof. 4. The implant as claimed in claim 1, wherein the porous material has a pore size ranging 50 to 1,000 .mu.m. 5. The implant as claimed in claim 1, wherein the cell block is a minced tissue block. 6. The implant as claimed in claim 1, wherein the cell block is a tissue block which is minced and enzyme-treated to release partial cells. 7. The implant as claimed in claim 1, wherein the enzyme is collagenase, hyaluronidase, trypsin, or proteinase, or a mixture thereof. 8. The implant as claimed in claim 1, wherein the implant is a bone implant. 9. The implant as claimed in claim 8, wherein the defect site is a joint. 10. The implant as claimed in claim 8, wherein the cell block is a cartilage tissue block minced from a cartilage tissue. 11. The implant as claimed in claim 8, wherein the cell block is a minced and enzyme-treated cartilage tissue to release partial cells and obtain an aggregate of tissue and cell. 12. The implant as claimed in claim 11, wherein the enzyme is collagenase. 13. The implant as claimed in claim 8, wherein the cell block is a cell aggregate of a chondrocyte. 14. The implant as claimed in claim 8, wherein the cell block is a granular carrier attached with a cell. 15. The implant as claimed in claim 1, wherein the size of the cell block is larger than the pore size of the porous material. 16. The implant as claimed in claim 1, wherein the cell block has a size ranging 100 to 2,000 .mu.m.

Details for Patent 8,183,042

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Bausch & Lomb Incorporated	VITRASE	hyaluronidase	Injection	021640	05/05/2004	⤷ Try a Trial	2025-12-29
Bausch & Lomb Incorporated	VITRASE	hyaluronidase	Injection	021640	12/02/2004	⤷ Try a Trial	2025-12-29
Amphastar Pharmaceuticals, Inc.	AMPHADASE	hyaluronidase	Injection	021665	10/26/2004	⤷ Try a Trial	2025-12-29
Akorn, Inc.	HYDASE	hyaluronidase	Injection	021716	10/25/2005	⤷ Try a Trial	2025-12-29
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965	⤷ Try a Trial	2025-12-29
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.